CORBUS PHARMACEUTICALS HOLDI (CRBP) Top Institutional Shareholders

CORBUS PHARMACEUTICALS HOLDI (CRBP) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $119.13M in CRBP holdings during the latest filing period.

Cormorant Asset Management, Lp is currently the largest disclosed institutional shareholder of CRBP tracked by InsiderSet, reporting ownership valued at approximately $22.02M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $18.88M, representing an estimated loss of -14.27% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 72% of the total disclosed CRBP value among the investors covered in this analysis. Major shareholders include Cormorant Asset Management, Lp, Orbimed Advisors Llc, Aberdeen Group Plc, and several other long-term asset managers with concentrated positions in CORBUS PHARMACEUTICALS HOLDI (CRBP).

This page ranks the largest institutional CRBP shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

105

Total Reported Value

$119.13M

Largest Holder

Cormorant Asset Management, Lp

Largest Position

$22.02M

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

119

Funds Exiting Positions

0

Page 1 of 3
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Cormorant Asset Management, Lp1.11%2,344,971$22,019,278$18,877,017-$3,142,261-14.27%
Orbimed Advisors Llc0.36%1,737,287$16,313,125$13,985,160-$2,327,965-14.27%
Aberdeen Group Plc0.02%1,321,750$12,411,233$10,640,088-$1,771,145-14.27%
Vanguard Capital Management Llc0.00%734,106$6,893,255$5,909,553-$983,702-14.27%
Citadel Advisors Llc0.00%727,060$6,827,094$5,852,833-$974,261-14.27%
Prosight Management, Lp1.07%697,108$6,545,844$5,611,719-$934,125-14.27%
Diadema Partners Lp1.71%439,957$4,131,196$3,541,654-$589,542-14.27%
Stonepine Capital Management, Llc3.19%383,462$3,600,708$3,086,869-$513,839-14.27%
Armistice Capital, Llc0.11%364,000$3,417,960$2,930,200-$487,760-14.27%
Renaissance Technologies LLCJim Simons0.01%346,998$3,258,311$2,793,334-$464,977-14.27%
Susquehanna International Group, Llp0.00%333,415$3,130,767$2,683,991-$446,776-14.27%
Adar1 Capital Management, Llc0.19%331,781$3,115,424$2,670,837-$444,587-14.27%
Blackrock, Inc.0.00%271,636$2,550,662$2,186,670-$363,992-14.27%
Exome Asset Management Llc1.29%234,136$2,198,537$1,884,795-$313,742-14.27%
Geode Capital Management, Llc0.00%187,029$1,757,021$1,505,583-$251,438-14.31%
Mirae Asset Global Etfs Holdings Ltd.0.00%160,462$1,506,738$1,291,719-$215,019-14.27%
Marshall Wace, Llp0.00%146,596$1,376,537$1,180,098-$196,439-14.27%
Dimensional Fund Advisors Lp0.00%136,602$1,281,362$1,099,646-$181,716-14.18%
Persistent Asset Partners Ltd0.41%111,226$1,044,412$895,369-$149,043-14.27%
Millennium Management Llc0.00%107,800$1,012,242$867,790-$144,452-14.27%
Vanguard Fiduciary Trust Co0.00%96,241$903,703$774,740-$128,963-14.27%
Goldman Sachs Group Inc0.00%93,111$874,313$749,544-$124,769-14.27%
Seven Fleet Capital Management Lp0.26%85,687$804,601$689,780-$114,821-14.27%
683 Capital Management, Llc0.07%85,543$803,249$688,621-$114,628-14.27%
Assenagon Asset Management S.A.0.00%85,246$800,460$686,230-$114,230-14.27%
Jane Street Group, Llc0.00%73,193$687,282$589,204-$98,078-14.27%
State Street Corp0.00%68,872$646,708$554,420-$92,288-14.27%
Balyasny Asset Management L.P.0.00%65,201$612,237$524,868-$87,369-14.27%
Simplex Trading, Llc0.02%52,836$496,130$425,330-$70,800-14.27%
Point72 Asset Management, L.P.0.00%51,296$481,669$412,933-$68,736-14.27%
Prelude Capital Management, Llc0.04%50,826$477,256$409,149-$68,107-14.27%
Verdad Advisers, Lp0.53%50,252$471,866$404,529-$67,337-14.27%
Rangeley Capital, Llc0.45%44,840$421,048$360,962-$60,086-14.27%
Northern Trust Corp0.00%41,504$389,723$334,107-$55,616-14.27%
Cantor Fitzgerald, L. P.0.01%40,098$376,512$322,789-$53,723-14.27%
Ubs Group Ag0.00%38,638$362,811$311,036-$51,775-14.27%
Xtx Topco Ltd0.01%38,023$357,036$306,085-$50,951-14.27%
Morgan Stanley0.00%32,854$308,499$264,475-$44,024-14.27%
Brevan Howard Capital Management Lp0.00%32,679$306,856$263,066-$43,790-14.27%
Jump Financial, Llc0.00%30,600$287,334$246,330-$41,004-14.27%
Royal Bank Of Canada0.00%29,901$281,000$240,703-$40,297-14.34%
Hudson Bay Capital Management Lp0.00%29,578$277,737$238,103-$39,634-14.27%
D. E. Shaw & Co., Inc.0.00%26,474$248,591$213,116-$35,475-14.27%
Velan Capital Investment Management Lp0.15%26,000$244,140$209,300-$34,840-14.27%
Vanguard Portfolio Management Llc0.00%24,365$228,787$196,138-$32,649-14.27%
Quadrature Capital Ltd0.00%22,986$215,839$185,037-$30,802-14.27%
Exchange Traded Concepts, Llc0.00%22,131$207,810$178,155-$29,655-14.27%
Pale Fire Capital Se0.02%21,350$200,477$171,868-$28,609-14.27%
Barclays Plc0.00%20,782$195,143$167,295-$27,848-14.27%
Laurion Capital Management Lp0.02%19,600$184,044$157,780-$26,264-14.27%

Frequently asked questions about CRBP

  • Who owns the most CRBP stock?

    The largest holders of CRBP are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for CORBUS PHARMACEUTICALS HOLDI (CRBP).

  • Is CRBP widely held by superinvestors?

    Many widely followed stocks like CRBP appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly CRBP is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.